Cognitive changes predict functional decline in ALS
Top Cited Papers
- 23 April 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 80 (17), 1590-1597
- https://doi.org/10.1212/wnl.0b013e31828f18ac
Abstract
Objective: To determine whether cognitive status in patients with amyotrophic lateral sclerosis (ALS) is a useful predictor of attrition and motor and cognitive decline. Methods: Cognitive testing was undertaken in a large population-based cohort of incident ALS patients using a longitudinal, case-control study design. Normative data for neuropsychological tests were generated using age-, sex-, and education-matched healthy controls who also underwent repeated assessments. Data were analyzed to generate models for progression/spread. Results: One hundred eighty-six patients with ALS who had no evidence of C9orf72 hexanucleotide repeat expansion were enrolled. A second and third assessment were undertaken in 98 and 46 of the patients with ALS, respectively. Executive impairment at the initial visit was associated with significantly higher rates of attrition due to disability or death and faster rates of motor functional decline, particularly decline in bulbar function. Decline in cognitive function was faster in patients who were cognitively impaired at baseline. Normal cognition at baseline was associated with tendency to remain cognitively intact, and with slower motor and cognitive progression. Conclusions: Non-C9orf72–associated ALS is characterized by nonoverlapping cognitive subgroups with different disease trajectories. These findings have important implications for models of ALS pathogenesis, and for future clinical trial design.Keywords
This publication has 30 references indexed in Scilit:
- On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementiaProgress in Neurobiology, 2011
- Executive dysfunction is a negative prognostic indicator in patients with ALS without dementiaNeurology, 2011
- The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trialsAmyotrophic Lateral Sclerosis, 2010
- Motor neuron disease and frontotemporal dementia: One, two, or three diseases?Annals of Indian Academy of Neurology, 2010
- A prospective cohort study of neuropsychological test performance in ALSAmyotrophic Lateral Sclerosis, 2009
- ALS motor phenotype heterogeneity, focality, and spreadNeurology, 2009
- Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2009
- Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004Journal of Neurology, Neurosurgery & Psychiatry, 2008
- Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal studyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983